DexCom Total Operating Expenses increased by 5.4% to $495.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.7%, from $455.30M to $495.00M. Over 4 years (FY 2021 to FY 2025), Total Operating Expenses shows an upward trend with a 7.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase faster than revenue growth suggests declining operating margins, while slower growth indicates effective cost control.
Total operating expenses represent the sum of all costs incurred to operate the business, excluding the cost of goods so...
Used to calculate operating margin; peers in the healthcare sector monitor this closely to manage profitability against R&D requirements.
total_operating_expenses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $316.10M | $328.60M | $472.00M | $356.80M | $372.50M | $346.70M | $415.90M | $415.40M | $418.30M | $417.80M | $439.70M | $460.80M | $468.70M | $441.80M | $466.90M | $455.30M | $476.20M | $488.90M | $469.70M | $495.00M |
| QoQ Change | — | +4.0% | +43.6% | -24.4% | +4.4% | -6.9% | +20.0% | -0.1% | +0.7% | -0.1% | +5.2% | +4.8% | +1.7% | -5.7% | +5.7% | -2.5% | +4.6% | +2.7% | -3.9% | +5.4% |
| YoY Change | — | — | — | — | +17.8% | +5.5% | -11.9% | +16.4% | +12.3% | +20.5% | +5.7% | +10.9% | +12.0% | +5.7% | +6.2% | -1.2% | +1.6% | +10.7% | +0.6% | +8.7% |